drugset / Trial / NCT04106206
A Safety Study of LY3372689 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
This study is being conducted to determine the safety profile of the study drug after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3372689 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive multiple doses of LY3372689 or placebo and will remain in the study for up to eight weeks.
Timeline
- Start
- 2019-10-23
- Primary completion
- 2020-02-12
- Completion
- 2020-02-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ceperognastat | Small molecule | — | Oral |
Indications
No indication recorded.